NCT06085781View on ClinicalTrials.gov

HN-BIO: A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

January 15, 2027

Study Completion Date

January 15, 2027

Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
OTHER

fMRI

Functional Magnetic Resonance Imaging

OTHER

Oral Pimonidazole

200 mg and 300 mg tablets

Trial Locations (1)

M5G 2M9

RECRUITING

Princess Margaret Cancer Center, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER